A possible mechanism for thalidomide teratogenicity has been suggested Animal 18 January 2013 Pages: 2 - 2
The US FDA should consider increasing the number of patients required for new drug application clinical trials News item 18 January 2013 Pages: 2 - 2
A pioglitazone [`Actos'] study involving patients who have previously discontinued troglitazone News item 18 January 2013 Pages: 3 - 3
Roche will supply monthly updates regarding cases of breast cancer in ongoing clinical trials of orlistat News item 18 January 2013 Pages: 3 - 3
US FDA warns public about new butyrolactone-related agents Media release 18 January 2013 Pages: 3 - 3
Doctors report more serious or unknown adverse drug events (ADEs) in hospitalised patients Clinical study 18 January 2013 Pages: 4 - 4
Indium-111 antimyosin scintigraphy may detect early heart damage Clinical study 18 January 2013 Pages: 4 - 4
Mizolastine did not affect ventricular repolarisation in healthy volunteers Volunteers 18 January 2013 Pages: 4 - 4
Nalmefene reduces the incidence of postoperative morphine-related adverse effects Clinical study 18 January 2013 Pages: 4 - 4
ATG and muromonab CD3 increase cancer risk in renal transplant Incidence study 18 January 2013 Pages: 5 - 5
Neurological disorders in heparin-induced thrombocytopenia Incidence study 18 January 2013 Pages: 6 - 6
Valproate semisodium better tolerated than valproic acid Incidence study 18 January 2013 Pages: 6 - 6
Vancomycin – low incidence of nephrotoxicity in neonates Incidence study 18 January 2013 Pages: 6 - 6
